Animal models of schizophrenia - PubMed (original) (raw)
Comparative Study
. 1981 Apr;138(4):478-83.
doi: 10.1176/ajp.138.4.478.
- PMID: 6782897
- DOI: 10.1176/ajp.138.4.478
Comparative Study
Animal models of schizophrenia
W T McKinney et al. Am J Psychiatry. 1981 Apr.
Abstract
The authors review some general issues concerning the development and use of animal models of schizophrenia and present a summary of the criteria necessary for validating models. They also describe some of the major attempts at creating animal models of schizophrenia, including drug and nondrug methods. They comment on the etiologic, phenomenologic, and treatment relevance of the various systems and suggest approaches that might produce improved animal models of schizophrenia.
Similar articles
- Neonatal domoic acid abolishes latent inhibition in male but not female rats and has differential interactions with social isolation.
Marriott AL, Tasker RA, Ryan CL, Doucette TA. Marriott AL, et al. Neurosci Lett. 2014 Aug 22;578:22-6. doi: 10.1016/j.neulet.2014.06.025. Epub 2014 Jun 19. Neurosci Lett. 2014. PMID: 24954074 - [Pain sensitivity changes in schizophrenic patients and animal models. Part 1].
Tuboly G, Horváth G. Tuboly G, et al. Ideggyogy Sz. 2009 Jan 30;62(1-2):4-11. Ideggyogy Sz. 2009. PMID: 19248722 Review. Hungarian. - Hallucinatory behaviors in primates produced by around-the-clock amphetamine treatment for several days via implanted capsules.
Nielsen EB, Eison MS, Lyon M, Iversen SD. Nielsen EB, et al. Prog Clin Biol Res. 1983;131:79-100. Prog Clin Biol Res. 1983. PMID: 6417669 No abstract available. - Amphetamine challenge: effects in previously isolated rhesus monkeys and implications for animal models of schizophrenia.
Kraemer GW, Ebert MH, Lake CR, McKinney WT. Kraemer GW, et al. Prog Clin Biol Res. 1983;131:199-218. Prog Clin Biol Res. 1983. PMID: 6647458 No abstract available. - The amphetamine-induced sensitized state as a model of schizophrenia.
Featherstone RE, Kapur S, Fletcher PJ. Featherstone RE, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1556-71. doi: 10.1016/j.pnpbp.2007.08.025. Epub 2007 Aug 28. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17884274 Review.
Cited by
- Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
Weiner I, Izraeli-Telerant A, Feldon J. Weiner I, et al. Psychopharmacology (Berl). 1987;91(3):345-51. doi: 10.1007/BF00518189. Psychopharmacology (Berl). 1987. PMID: 3104957 - The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.
Tseng KY, Chambers RA, Lipska BK. Tseng KY, et al. Behav Brain Res. 2009 Dec 7;204(2):295-305. doi: 10.1016/j.bbr.2008.11.039. Epub 2008 Dec 3. Behav Brain Res. 2009. PMID: 19100784 Free PMC article. Review. - Corticosterone antagonist or TrkB agonist attenuates schizophrenia-like behavior in a mouse model combining Bdnf-e6 deficiency and developmental stress.
Chen Y, Li S, Zhang T, Yang F, Lu B. Chen Y, et al. iScience. 2022 Jun 16;25(7):104609. doi: 10.1016/j.isci.2022.104609. eCollection 2022 Jul 15. iScience. 2022. PMID: 35789832 Free PMC article. - A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.
Lipska BK, Weinberger DR. Lipska BK, et al. Neurotox Res. 2002 Aug-Sep;4(5-6):469-475. doi: 10.1080/1029842021000022089. Neurotox Res. 2002. PMID: 12754160
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical